Clinical Trials

Rheumatoid Arthritis & Interstitial Lung Disease Medication

Do you have rheumatoid arthritis and interstitial lung disease (RA-ILD)? You may be able to help our researchers determine if people with RA-ILD can benefit from a medication called Pirfenidone, which has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic pulmonary fibrosis (IPF).

Learn More

Reasons to Choose National Jewish Health

  • The leading respiratory hospital in the nation and the only one devoted fully to the treatment of respiratory and related illnesses
  • Ranked as one of the top two hospitals in pulmonology every year since U.S. News & World Report included this category in its annual “Best Hospitals” survey
  • Ranked in the top 1 percent of hospitals in the nation by HCAHPS
  • Physicians consistently recognized among the best in the nation by multiple services, including Best Doctors in America and Castle Connolly
  • Among the top 6 percent of organizations funded for research by the NIH, providing patients access to more than 300 active clinical trials
  • 121-year history of focus on care, research and education serving thousands of patients with lung, heart, immune and related disorders